2018 cohort company Ejenta spoke at HIMSS on Health Advancements and Human Spaceflight. The Space Exploration road map now includes planning for missions that are increased in duration and distance from earth and with more diverse crew members. This has dramatically increased the demand for advanced augmented, autonomous supportive technologies. Learn more here.
2018 cohort company Explorer Surgical has expanded its presence in the pediatric orthopedic medical device space with the announcement of its newest customer, Pega Medical. Specializing in the design, development, evaluation and manufacturing of medical devices for pediatric orthopedics, Pega Medical was founded in 1996 and its implantable devices reach children living with orthopedic conditions in more than 70 countries, including within multiple top-tier children's hospitals. Learn more here.
2018 cohort company Lapovations recently participated in the prestigious Texas Life Sciences Forum in Houston, Texas, and was selected as one of the “10 Most Promising Companies.” The Texas Life Science Forum is the premier life science event in Texas that brings emerging life science companies together with academics, investors, and industry professionals. Learn more here.
2019 cohort company Droice Labs conducted a webinar to discuss ways to effectively harness patient data for real-world impact. Real-world patient data was not collected with the goal to personalize patient care, yet many attempts to repurpose this data for finding optimal treatments focus on fitting messy, noisy, and biased real-world data into pristine data models. This not only requires expensive and time-consuming cleaning processes but also strips away potentially valuable signals. Watch the webinar here.
2020 cohort company Raydian Oximetry won the Platinum Award at the UCSF-Stanford Pediatric Device Consortium Accelerator Pitch Competition. Learn more here.